Opting for enteric-coated aspirin over the uncoated pills doesn’t appear to have a major impact on the drug’s antiplatelet effects in patients with atherosclerotic CVD, but nor did it offer an edge in ...
This was a post hoc analysis of the 2021 open-label randomized ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness) trial that showed no statistical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback